Status:
RECRUITING
MITIGAAT: Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants
Lead Sponsor:
Medical University of South Carolina
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Medication Adherence
Medication Compliance
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a randomized study to test a smartphone app that a pharmacist will use to help kidney transplant patients track their medications, blood pressures, and blood sugars in those with diabetes. The...
Detailed Description
The overarching hypothesis for MITIGAAT is that late non-adherence and suboptimal control of diabetes and hypertension are more common in African American kidney recipients and are major contributors ...
Eligibility Criteria
Inclusion
- ≥18 years of age
- ≥2 years post-kidney transplant
Exclusion
- Non-kidney transplant recipient (liver, lung, heart, intestine, pancreas, bone marrow)
- Not capable of measuring own BP and glucose in those with diabetes
- Not capable of using mobile health application after adequate training
- Not capable of speaking, hearing, and reading English
Key Trial Info
Start Date :
February 27 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2027
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT06023615
Start Date
February 27 2024
End Date
October 31 2027
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425